Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
6.93
+0.42 (6.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
Monte Rosa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 426 | 283 | 368 | 950 | - | - |
| Market Cap Growth | 36.73% | -23.21% | -61.22% | - | - | - |
| Enterprise Value | 227 | 151 | 142 | 583 | - | - |
| Last Close Price | 6.93 | 5.65 | 7.61 | 20.42 | - | - |
| PB Ratio | 2.07 | 1.58 | 1.36 | 2.73 | - | - |
| P/TBV Ratio | 1.58 | 1.58 | 1.36 | 2.73 | - | - |
| Debt / Equity Ratio | 0.21 | 0.26 | 0.17 | - | - | 0.11 |
| Quick Ratio | 5.83 | 5.00 | 10.58 | 20.80 | 1.43 | 1.41 |
| Current Ratio | 6.03 | 5.07 | 10.79 | 20.96 | 1.49 | 2.27 |
| Return on Equity (ROE) | -61.23% | -60.07% | -35.06% | -40.35% | -277.72% | - |
| Return on Assets (ROA) | -28.43% | -27.72% | -19.82% | -21.91% | -57.90% | - |
| Return on Capital (ROIC) | -33.58% | -32.95% | -21.10% | -24.85% | -131.69% | - |
| Earnings Yield | -28.04% | -47.85% | -29.46% | -7.79% | - | - |
| FCF Yield | -14.75% | -22.22% | -28.61% | -7.28% | - | - |
| Buyback Yield / Dilution | -36.96% | -8.83% | -88.91% | -1548.09% | -7.11% | - |
| Total Shareholder Return | -36.96% | -8.83% | -88.91% | -1548.09% | -7.11% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.